Detalhe da pesquisa
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331190
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
3.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol
; 35(2): 202-215, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082486
4.
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.
Clin Exp Nephrol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643286
5.
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.
Eur Heart J
; 44(13): 1157-1166, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36691956
6.
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
Nephrol Dial Transplant
; 38(11): 2444-2455, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230946
7.
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE.
BMC Nephrol
; 24(1): 310, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880609
8.
In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.
Ann Intern Med
; 175(5): JC54, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500259
9.
In CKD, the Kidney Failure Risk Equation predicted 2-y risk for ESKD better than eGFR alone.
Ann Intern Med
; 175(5): JC59, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500267
10.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
11.
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
JAMA
; 330(13): 1266-1277, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787795
12.
Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review.
J Card Fail
; 28(11): 1628-1641, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038013
13.
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
J Am Soc Nephrol
; 32(1): 127-137, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127858
14.
Empagliflozin in Patients with Chronic Kidney Disease. Reply.
N Engl J Med
; 388(24): 2301-2302, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314723
15.
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
Am J Kidney Dis
; 78(3): 350-360.e1, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895181
16.
In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
Ann Intern Med
; 173(4): JC17, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32805174
17.
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
Ann Intern Med
; 173(4): JC16, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32805175
18.
Blood pressure and kidney disease: chicken or egg (or both)?
Kidney Int
; 98(3): 547-549, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32828236
19.
International consensus definitions of clinical trial outcomes for kidney failure: 2020.
Kidney Int
; 98(4): 849-859, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998816
20.
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.
Int J Obes (Lond)
; 44(11): 2256-2266, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678323